secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2026-06-05T20:10:37+00:00
Accession:  0001005286-26-000023
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore stockholders approve 2026 equity plan; all director nominees elected at annual meeting
--------------------------------------------------------------------------------

- Stockholders approved 2026 Stock Incentive Plan (2.5M new shares plus forfeited 2019 Plan shares) effective Oct 16, 2026.
- All nine director nominees elected: 7 by all stockholders (Houde, Antunes, Johnson, Josephs, Korenberg, Obus, Schechter); 2 by Series A preferred (Aryeh, Kiper).
- Ratified KPMG as auditor (33.8M for); approved non-binding say-on-pay (22.9M for).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528626000023/0001005286-26-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528626000023/lfcr-20260604.htm
  HTML page:      https://secwatch.observer/filing/0001005286-26-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer